Hegab Z, Gibbons S, Neyses L, Vassalle C, Monasterio G. Role of advanced glycation end products in cardiovascular disease. World J Cardiol. 2012;4:90.
Article PubMed PubMed Central Google Scholar
Raghavan CT. Advanced glycation end products in neurodegenerative diseases. J Mol Neurosci. 2024;74:114.
Ma Y, Wang X, Lin S, King L, Liu L. The potential role of advanced glycation end products in the development of kidney disease. Nutrients. 2025; 17. https://doi.org/10.3390/NU17050758.
Degen J, Hellwig M, Henle T. 1,2-dicarbonyl compounds in commonly consumed foods. J Agric Food Chem. 2012;60:7071–9.
Thornalley PJ, Battah S, Ahmed N, Karachalias N, Agalou S, Babaei-Jadidi R, et al. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem J. 2003;375:581–92.
Article PubMed PubMed Central Google Scholar
Ribeiro RT, Macedo MP, Raposo JF. HbA1c, fructosamine, and glycated albumin in the detection of dysglycaemic conditions. Curr Diab Rev. 2016;12:14–9.
Gerrits EG, Smit AJ, Bilo HJG. AGEs, autofluorescence and renal function. Nephrol Dial Transpl. 2009;24:710–3.
Meerwaldt R, Lutgers HL, Links TP, Graaff R, Baynes JW, Gans ROB, et al. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diab Care. 2007;30:107–12.
Hellwig M, Humpf HU, Hengstler J, Mally A, Vieths S, Henle T. Quality criteria for studies on dietary glycation compounds and human health. J Agric Food Chem. 2019;67:11307–11.
Hellwig M, Diel P, Eisenbrand G, Grune T, Guth S, Henle T, et al. Dietary glycation compounds—implications for human health. Crit Rev Toxicol. 2024;54:485–617.
Rungratanawanich W, Qu Y, Wang X, Essa MM, Song BJ. Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury. Exp Mol Med. 2021;53:168–88.
Article PubMed PubMed Central Google Scholar
Scheijen JLJM, Clevers E, Engelen L, Dagnelie PC, Brouns F, Stehouwer CDA, et al. Analysis of advanced glycation endproducts in selected food items by ultra-performance liquid chromatography tandem mass spectrometry: presentation of a dietary AGE database. Food Chem. 2016;190:1145–50.
Cordova R, Knaze V, Viallon V, Rust P, Schalkwijk CG, Weiderpass E, et al. Dietary intake of advanced glycation end products (AGEs) and changes in body weight in European adults. Eur J Nutr. 2020;59:2893–904.
U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans; 2020–2025. U.S. Department of Agriculture and U.S. Department of Health and Human Services; 2024. https://health.gov/our-work/nutrition-physical-activity/dietary-guidelines (accessed 30 Sept 2024).
Lombardo M, Amoah I, Feraco A, Guseva E, Gorini S, Camajani E, et al. Gender differences in taste and food habits: implications for personalized nutrition. Biol Life Sci Forum. 2023;29:1.
Barrea L, Verde L, Suárez R, Frias-Toral E, Vásquez CA, Colao A, et al. Sex-differences in Mediterranean diet: a key piece to explain sex-related cardiovascular risk in obesity? A cross-sectional study. J Transl Med. 2024;22:1–13.
Feraco A, Armani A, Amoah I, Guseva E, Camajani E, Gorini S, et al. Assessing gender differences in food preferences and physical activity: a population-based survey. Front Nutr. 2024; 11. https://doi.org/10.3389/FNUT.2024.1348456.
Gil M, Rudy M, Stanisławczyk R, Duma-Kocan P, Żurek J. Gender differences in eating habits of polish young adults aged 20-26. Int J Environ Res Public Health. 2022; 19. https://doi.org/10.3390/IJERPH192215280.
Hilger J, Loerbroks A, Diehl K. Eating behaviour of university students in Germany: dietary intake, barriers to healthy eating and changes in eating behaviour since the time of matriculation. Appetite. 2017;109:100–7.
Lee SWH, Ng KY, Chin WK. The impact of sleep amount and sleep quality on glycemic control in type 2 diabetes: a systematic review and meta-analysis. Sleep Med Rev. 2017;31:91–101.
Santos HO, Penha-Silva N. Translating the advanced glycation end products (AGEs) knowledge into real-world nutrition strategies. Eur J Clin Nutr. 2022;76:922–8.
Dorans KS, Bazzano LA, Qi L, He H, Chen J, Appel LJ, et al. Effects of a low-carbohydrate dietary intervention on hemoglobin A1c: a randomized clinical trial. JAMA Netw Open. 2022;5:E2238645.
Article PubMed PubMed Central Google Scholar
Swaminathan K, Clemens DL, Dey A. Inhibition of CYP2E1 leads to decreased malondialdehyde-acetaldehyde adduct formation in VL-17A cells under chronic alcohol exposure. Life Sci. 2013;92:325–36.
Gaens KHJ, Goossens GH, Niessen PM, Van Greevenbroek MM, Van Der Kallen CJH, Niessen HW, et al. Nε-(carboxymethyl)lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistance. Arterioscler Thromb Vasc Biol. 2014;34:1199–208.
Sergi D, Boulestin H, Campbell FM, Williams LM. The role of dietary advanced glycation end products in metabolic dysfunction. Mol Nutr Food Res. 2021; 65. https://doi.org/10.1002/MNFR.201900934.
Centers for Disease Control and Prevention. Chronic Kidney Disease in the United States, 2023. US Department of Health and Human Services, Atlanta; GA: 2023.
Taguchi K, Fukami K. RAGE signaling regulates the progression of diabetic complications. Front Pharmacol. 2023; 14. https://doi.org/10.3389/fphar.2023.1128872.
Buetler TM, Leclerc E, Baumeyer A, Latado H, Newell J, Adolfsson O, et al. N(epsilon)-carboxymethyllysine-modified proteins are unable to bind to RAGE and activate an inflammatory response. Mol Nutr Food Res. 2008;52:370–8.
Zenker HE, Ewaz A, Deng Y, Savelkoul HFJ, Van Neerven RJJ, De Jong N, et al. Differential effects of dry vs. wet heating of β-lactoglobulin on formation of sRAGE binding ligands and sIgE epitope recognition. Nutrients. 2019;11:1432.
Article PubMed PubMed Central Google Scholar
Lin N, Zhang H, Su Q. Advanced glycation end-products induce injury to pancreatic beta cells through oxidative stress. Diab Metab. 2012;38:250–7.
Wang X-J, Ma S-B, Liu Z-F, Li H, Gao W-Y. Elevated levels of α-dicarbonyl compounds in the plasma of type II diabetics and their relevance with diabetic nephropathy. J Chromatogr B Anal Technol Biomed Life Sci. 2019;1106–1107:19–25.
Tezuka Y, Nakaya I, Nakayama K, Nakayama M, Yahata M, Soma J. Methylglyoxal as a prognostic factor in patients with chronic kidney disease. Nephrol. 2019;24:943–50.
Yoshida Y, Chen Z, Fonseca VA, Mauvais-Jarvis F. Sex differences in cardiovascular risk associated with prediabetes and undiagnosed diabetes. Am J Prev Med. 2023;65:854–62.
Norhammar A. Diabetes and cardiovascular mortality: the impact of sex. Lancet Diab Endocrinol. 2018;6:517–9.
Lambrinoudaki I, Paschou SA, Armeni E, Goulis DG. The interplay between diabetes mellitus and menopause: clinical implications. Nat Rev Endocrinol. 2022;18:608–22.
Erdélyi A, Pálfi E, Tűű L, Nas K, Szűcs Z, Török M, et al. The importance of nutrition in menopause and perimenopause—a review. Nutrients. 2024; 16. https://doi.org/10.3390/nu16010027.
Uribarri J, Cai W, Peppa M, Goodman S, Ferrucci L, Striker G, et al. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci. 2007;62:427–33.
Pereira-Simon S, Rubio GA, Xia X, Cai W, Choi R, Striker GE, et al. Inhibition of advanced glycation end products (AGEs) accumulation by pyridoxamine modulates glomerular and mesangial cell estrogen receptor α expression in aged female mice. PLoS ONE. 2016; 11. https://doi.org/10.1371/JOURNAL.PONE.0159666.
Jaisson S, Gillery P. Methods to assess advanced glycation end-products. Curr Opin Clin Nutr Metab Care. 2021;24:411–5.
Corica D, Pepe G, Currò M, Aversa T, Tropeano A, Ientile R, et al. Methods to investigate advanced glycation end-product and their application in clinical practice. Methods. 2022;203:90–102.
Monnier VM, Sell DR, Gao X, Genuth SM, Lachin JM, Bebu I. Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC. BMJ Open Diabetes Res Care. 2022; 10. https://doi.org/10.1136/BMJDRC-2021-002667.
Koska J, Saremi A, Howell S, Bahn G, De Courten B, Ginsberg H, et al. Advanced glycation end products, oxidation products, and incident cardiovascular events in patients with type 2 diabetes. Diab Care. 2018;41:570–6.
Bajwa S, Luebbe A, Vo NDN, Piskor EM, Kosan C, Wolf G, et al. RAGE is a critical factor of sex-based differences in age-induced kidney damage. Front Physiol. 2023; 14. https://doi.org/10.3389/fphys.2023.1154551.
Du Z, Wu J, Feng Z, Ma X, Zhang T, Shu X, et al. RAGE displays sex-specific differences in obesity-induced adipose tissue insulin resistance. Biol Sex Differ. 2022; 13. https://doi.org/10.1186/S13293-022-00476-6.
Moreno-Navarrete JM, Leal Y, Rosell-Díaz M, Fernández-Real JM. Soluble receptors for advanced glycation endproducts are predictors of insulin sensitivity and affected by weight loss. Nutr Diab. 2024;14:88.
Comments (0)